[go: up one dir, main page]

HUP9904073A2 - Bizmutot és nemszteroid gyulladásgátló hatóanyagot tartalmazó készítmények gasztrointesztinális rendellenességek kezelésére - Google Patents

Bizmutot és nemszteroid gyulladásgátló hatóanyagot tartalmazó készítmények gasztrointesztinális rendellenességek kezelésére

Info

Publication number
HUP9904073A2
HUP9904073A2 HU9904073A HUP9904073A HUP9904073A2 HU P9904073 A2 HUP9904073 A2 HU P9904073A2 HU 9904073 A HU9904073 A HU 9904073A HU P9904073 A HUP9904073 A HU P9904073A HU P9904073 A2 HUP9904073 A2 HU P9904073A2
Authority
HU
Hungary
Prior art keywords
treatment
gastrointestinal disorders
nsaid
compositions
containing bismuth
Prior art date
Application number
HU9904073A
Other languages
English (en)
Inventor
Owen Rickford Carryl
Jonathan Davidson Kaunitz
Shin Tanaka
Original Assignee
The Procter & Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Co. filed Critical The Procter & Gamble Co.
Publication of HUP9904073A2 publication Critical patent/HUP9904073A2/hu
Publication of HUP9904073A3 publication Critical patent/HUP9904073A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát a Helicőbacter pylőri által őkőzőtt vagyközvetített gasztőrintesztinális rendellenességek kezelésére szőlgálókészítmények képezik, amelyekkel a betegnek bizműtőt és egynemszterőid gyűladásgátló hatóanyag gasztrőpatikűs mennyiségét adjákbe. A készítmény tartalmazhatja tővábbá egy vagy több antiszekrécióshatóanyag terápiásan hatékőny mennyiségét is. ŕ
HU9904073A 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid HUP9904073A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
HUP9904073A2 true HUP9904073A2 (hu) 2000-03-28
HUP9904073A3 HUP9904073A3 (en) 2000-04-28

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904073A HUP9904073A3 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Country Status (7)

Country Link
EP (1) EP0941102A1 (hu)
CN (1) CN1238694A (hu)
CA (1) CA2271381A1 (hu)
HU (1) HUP9904073A3 (hu)
NO (1) NO992468L (hu)
TR (1) TR199901101T2 (hu)
WO (1) WO1998022118A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
JP2002537336A (ja) * 1999-02-26 2002-11-05 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
ATE511508T1 (de) * 2000-12-01 2011-06-15 Takeda Pharmaceutical Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
ES2534713T3 (es) 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
KR20100123758A (ko) 2008-03-10 2010-11-24 다케다 야쿠힌 고교 가부시키가이샤 벤즈이미다졸 화합물의 결정
CN102209529A (zh) 2008-09-09 2011-10-05 阿斯利康(瑞典)有限公司 将药物组合物递送至有需要的患者的方法
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088L (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
BR9206796A (pt) * 1991-11-22 1995-05-02 Procter & Gamble Forma de dose unitária de subsalicilato de bismuto
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra

Also Published As

Publication number Publication date
WO1998022118A1 (en) 1998-05-28
CA2271381A1 (en) 1998-05-28
HUP9904073A3 (en) 2000-04-28
NO992468D0 (no) 1999-05-21
NO992468L (no) 1999-07-01
EP0941102A1 (en) 1999-09-15
TR199901101T2 (xx) 1999-07-21
CN1238694A (zh) 1999-12-15

Similar Documents

Publication Publication Date Title
HUP9904073A2 (hu) Bizmutot és nemszteroid gyulladásgátló hatóanyagot tartalmazó készítmények gasztrointesztinális rendellenességek kezelésére
HK1035335A1 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents p romoting the healing of wounds, to the upper respiratory tract and/or the ear
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
PL318954A1 (en) Encapsulated composition of venafaxine hydrochloride of prolonged release
HUP0001527A2 (hu) Laktózmentes, nem higroszkópos és vízmentes dekarboetoxiloratadin-tartalmú gyógyászati készítmények
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
NO157102C (no) AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
GB9103764D0 (en) Compositions
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
NO983465L (no) Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
HUP9900978A2 (hu) Dioszgenint tartalmazó készítmény
EP0744176A3 (en) Methods for inhibiting bone loss
CA2330424A1 (en) Improved method for eradication of helicobacter pylori
GEP20043377B (en) Pharmaceutical Complex
ZA971036B (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections.
FR2759587B1 (fr) Composition pharmaceutique pour l'administration buccale de thiocolchicoside
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
FR2701709B1 (fr) Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.
IL124730A (en) Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions